Private demand is rising - and affordability matters more than ever
Private healthcare in the UK is no longer a niche option for a small group. Demand is holding near record levels, and the way patients pay is shifting.
PHIN data shows private admissions reached 242,500 in Q1 2026, just 1% below the peak, with insured admissions up 1% to around 152,500 and self-pay down 6% to 65,500. In other words, insured demand looks stable, and affordability pressures are changing self-pay behaviour. Looking back, Q3 2025 admissions were also up 1% UK-wide to 230,340, with a funding split that remains broadly consistent at around 70% insurance and 30% self-pay, and NHS-funded activity in private hospitals steady at about 5%.
At the same time, costs are rising quickly. UK healthcare inflation was 10.6% in 2025 and is projected around 10% in 2026, among the highest in Western Europe. That combination - sustained demand plus higher treatment prices - is exactly why more providers are exploring regulated, transparent ways for patients to spread the cost.
Finance can improve access, but only when it is offered clearly, fairly, and with the right safeguards in place.
The businesses this guide is written for
This is for UK private healthcare businesses that want to offer finance to patients in a responsible way. That includes independent hospitals, clinics, outpatient centres, specialist practices (for example, orthopaedics, ophthalmology, dermatology), diagnostic providers, and dental or cosmetic providers operating within healthcare pathways.
It is especially relevant if you serve working-age adults, because PMI coverage is rising most strongly in mid-career groups. The Actuary reports 7.6 million UK adults (14%) held PMI in 2024, with 35-54 year olds highest at around 18-19%. If your patient base includes employed professionals, employer-funded PMI members, or self-pay patients facing higher prices, patient finance can be a practical part of your payment mix.
What it means to “offer finance” in private healthcare
Offering finance means giving patients a structured, pre-agreed way to pay for treatment over time, rather than paying the full amount upfront. In practice, this can range from instalment plans managed by a third-party lender, to 0% interest promotional options (where commercially viable), to longer-term credit agreements for higher-cost procedures.
The commercial case is underpinned by the size and momentum of the market. LaingBuisson reports PMI now covers more than 4.8 million people (with market value reaching £7.9 billion and year-on-year growth of 4.5%), driven by NHS waiting lists. Separately, the wider UK private healthcare market was valued at around $13.6 billion in 2025, projected to rise to $17.2 billion by 2032 at 3.4% CAGR.
Just as important as “what it is” is “what it is not”. Patient finance is not a way to push people into treatment they cannot afford. Done properly, it is a tool to help patients make informed choices, with clear pricing, clear eligibility, and clear consequences if they miss payments.
How to set it up in a way that patients can trust
Start with your patient journey, not the finance product. Patients should understand treatment options, total price, what is included, and what is not included, before finance is even discussed.
Operationally, most providers choose a third-party finance partner so affordability checks, credit decisions, agreement documentation, and repayments are managed by a regulated lender. Your job is to integrate it smoothly: train teams to explain options in plain English, ensure quotes are consistent, and make sure the patient sees the same total cost whether they pay upfront or via finance (unless interest applies, which must be shown clearly).
Digital delivery matters now. Over 70% of new PMI policyholders engage digitally for services such as virtual GPs, so patients increasingly expect online estimates, e-signing, and clear next steps. Build finance into your digital touchpoints: treatment pages, price lists, and booking confirmations, with careful wording.
Finally, design for regional reality. PHIN data shows Wales differs from the UK-wide picture: in Q3 2025, self-pay made up 57% of admissions in Wales (insurance 43%). If you operate in self-pay heavy areas, the right finance structure can be the difference between a booking and a drop-off.
Why patient finance is becoming a strategic necessity
Three forces are pushing patient finance from “nice to have” into “expected”.
First, NHS access pressures are reshaping demand. Multiple reports point to ongoing NHS strain in 2026, including cost and workforce pressures and long waits. Patients who want certainty and speed are choosing private routes, and admissions remain near record highs.
Second, affordability is tightening. With healthcare inflation projected around 10% into 2026, self-pay patients feel price rises directly. Even insured patients may face shortfalls, exclusions, excesses, and limited outpatient allowances. Transparent finance can help patients bridge the gap without compromising clarity.
Third, the market is large and still growing. UK healthcare spending is forecast at 11.2% of GDP (£268 billion) in 2026, up from 11.1% (£258 billion) in 2025. Independent acute hospitals (including NHS PPUs) exceeded £8 billion in 2024 for the first time. These are strong signals that the ecosystem is expanding, and providers who make payment smoother often capture more of that demand.
Finance does not create demand by itself. It removes a barrier when demand already exists.
Pros and cons at a glance
| Pros | Cons |
|---|---|
| Can increase conversion from enquiry to booking by lowering upfront cost | Risk of patient dissatisfaction if terms are unclear or staff oversimplify |
| Helps patients manage higher prices during 10%+ healthcare inflation | Some patients will be declined after credit checks, which needs sensitive handling |
| Supports predictable cash flow when using a lender-funded model | Fees and merchant costs can reduce margins if not priced carefully |
| Fits digital-first patient expectations, especially for working-age adults | Adds operational complexity: training, scripts, governance, and complaint handling |
| Useful in self-pay heavy regions (for example, Wales at 57% self-pay) | Reputational risk if finance feels pushy or is positioned before clinical suitability |
| Complements PMI pathways where patients have shortfalls or elective upgrades | Regulatory and compliance obligations may apply depending on your model |
Key risks and “gotchas” to protect patients and your brand
The biggest risks rarely come from the finance product itself. They come from how it is explained.
Be careful with language. Avoid phrases that imply guaranteed approval, “instant acceptance”, or that a patient should choose finance rather than reconsider timing or alternatives. Patients must not feel nudged into borrowing.
Be equally careful with price transparency. Patients should see the total cost, any deposit, the number of repayments, the total repayable, and the APR (where interest applies). If 0% is offered, explain what happens if payments are missed. If a promotion is time-limited, make that clear.
You also need to manage clinical and ethical boundaries. Finance should only be discussed after clinical suitability and informed consent. For insured patients, make clear what insurance covers and what it does not, because “insured” is not the same as “fully covered”.
Finally, pay attention to regional funding patterns and case mix. UK-wide admissions are around 70% insurance and 30% self-pay, but Wales is the exception with self-pay dominating. If you copy-paste one payment approach across all sites, you can end up under-serving the patients who most need flexibility.
Other ways to help patients pay (besides credit)
- Deposit-based staged payments - split fees across milestones (for example, booking, pre-op, post-op).
- Package pricing - clear “all-in” bundles that reduce surprise extras and help patients plan.
- Pay-in-full discounts - a small, transparent discount for upfront payment (where commercially viable).
- Employer or corporate arrangements - pathways that align with employer-funded PMI schemes.
- Insurance-first support - admin help to confirm benefits, pre-authorisation, and shortfall estimates.
- Subscription or membership models - predictable monthly fees for defined services (only if clinically appropriate and clearly scoped).
FAQs patients and providers ask most often
It depends on the structure. If a regulated lender provides the credit agreement, they carry key regulatory responsibilities, but you may still have obligations around financial promotions and fair customer outcomes. Take proper legal and compliance advice for your exact model.
Should we offer finance to insured patients too?
Often, yes. Even with PMI, patients can have excesses, exclusions, outpatient caps, or upgrades they choose to self-fund. With insured admissions rising to around 152,500 in Q1 2026, this is a meaningful segment.
What repayment terms work best?
There is no single best term. Many providers offer a small number of clear options (for example, 6, 10, 12, or 24 months) to avoid confusion. The right range depends on typical treatment values and your patient demographic.
How do we talk about finance without sounding sales-led?
Put it after clinical suitability and price clarity. Use neutral wording: “If spreading the cost would help, there are payment options we can explain.” Always confirm the patient has understood totals and terms.
What about regions where self-pay is higher?
Adapt your approach. Wales is a standout example: in Q3 2025, 57% of admissions were self-pay. In those areas, finance options and clear staged-payment alternatives can be central, not optional.
Will offering finance increase complaints?
It can if terms are unclear or staff are not trained. Done well, it often reduces friction because patients understand affordability earlier. Build scripts, quality checks, and a clear escalation path.
How Switcha can help UK providers compare options clearly
Switcha is a UK price comparison website. We help businesses cut through complexity by comparing options in plain English, with transparent information so you can decide what fits your patients and your operating model. If you are exploring patient finance, we can support your research by signposting the key features to compare, the questions to ask providers, and the red flags to avoid so you can move forward with confidence.
Disclaimer
This article is for general information only and is not financial, legal, or regulatory advice. Finance products and regulatory responsibilities vary by provider and by the way finance is offered. Always check terms carefully and take professional advice where needed before making decisions or offering credit to patients.
